METABOLIC BIOMARKER
Biomarkers (or biological markers) are biological measures which capture what is happening in a cell or organism at a given moment. They represent objective medical signs (as opposed to symptoms reported by the patient) used to measure the presence or progress of disease, or the effects of treatment. They are four types of biomarkers: Molecular (e.g. blood glucose), physiologic (e.g. blood pressure), histologic (e.g. grading and staging of cancers) and radiographic (e.g. Bone mineral density).
They are used in many useful applications in health care such as screening, diagnostic, safety, monitoring, susceptibility, cancer detection and drug development.
Liver Biomarkers
Biomarker research represents an evolving area within hepatology. The main functions of the liver include detoxification, metabolism, bile secretion, hemopoietic blood storage and regulation of circulating blood volume, immune defense and regeneration.
Several biomarkers are used in the diagnosis and monitoring of liver injury and liver disease. They can provide information about oxidative stress, nuclear damage, the mode of cell death, inflammation and mitochondrial.
AMSBIO is offering an extensive range of products involved in this metabolic pathway as follows:
Kidney Biomarkers
Kidney function refers to the function of kidney excreting metabolic waste, maintaining the stability of sodium, potassium, calcium and other electrolytes and the function of acid-base balance. Kidney function estimation was commonly made using serum creatinine concentration, blood urea nitrogen (BUN) level and urine analysis.
There are two types of kidney disorders: Acute kidney injury (AKI) and chronic kidney disease (CKD). Their diagnosis relies on biomarkers that assess kidney function.
AMSBIO is offering an extensive range of products involved in this metabolic pathway as follows:
Cancer Biomarkers
A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. Biomarker testing helps characterize alterations in the tumor.
There is a lot of focus on developing new targeted therapy drugs that disrupt key drivers of cancer growth. Cancer biomarker research focuses on four areas:
-
- Immunotherapy response
- Liquid biopsies
- Minimal residual disease
- Pharmacodynamic markers
AMSBIO is offering an extensive range of products involved in this metabolic pathway as follows:
Other Biomarkers
AMSBIO is offering an extensive range of other biomarkers involved in this metabolic pathway as follows:
